Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home ETF

Is India’s Market Rally Losing Steam? FLIN ETF Faces Critical Test

Felix Baarz by Felix Baarz
September 29, 2025
in ETF
0
Franklin FTSE India ETF Stock
0
SHARES
100
VIEWS
Share on FacebookShare on Twitter

The Franklin FTSE India ETF (FLIN) is navigating turbulent waters as foreign capital exits the market amidst a significant equity downturn. This challenging environment emerges even as domestic investors demonstrate unprecedented confidence, opening record numbers of new trading accounts. The combined effect has pushed major Indian benchmarks toward their first negative annual performance since 2020.

Domestic Optimism Counters Foreign Exodus

A dramatic shift in investment patterns is unfolding across Indian markets. Foreign portfolio investors liquidated holdings worth ₹30,141.68 crore during September 2025 alone, following even larger outflows of ₹46,902.92 crore the previous month. This substantial capital flight has exerted considerable pressure on key indices, with the Sensex declining 5.5% and the Nifty 50 dropping 5.05% year-to-date.

Counterbalancing this foreign retreat, India’s domestic investor base continues to expand at an impressive rate. The country now boasts 120 million registered domestic investors, with 2.9 crore new Systematic Investment Plan accounts activated between April and August 2025. This substantial growth signals persistent optimism among local market participants despite the challenging conditions.

Performance Metrics Reflect Growing Pressure

Recent performance data reveals a concerning trend for the India-focused ETF:

  • One-week performance: -0.83%
  • One-month performance: -0.60%
  • Three-month performance: -1.21%
  • Year-to-date performance: +5.32%

While the fund maintains positive returns for the calendar year, a clear downward trajectory has emerged in shorter timeframes. Trading activity remains robust with approximately 367,620 shares changing hands daily, providing sufficient liquidity for larger positions.

Should investors sell immediately? Or is it worth buying Franklin FTSE India ETF?

Concentration Risk in Financial Heavyweights

The FLIN ETF maintains 267 individual holdings, yet its performance remains heavily dependent on a select few companies. The ten largest positions collectively account for 33% of the fund’s total assets, creating significant concentration in India’s corporate leaders:

  • HDFC Bank Ltd: 6.95%
  • Reliance Industries Ltd: 5.97%
  • ICICI Bank Ltd: 4.70%
  • Bharti Airtel Ltd: 3.29%
  • Infosys Ltd: 3.21%

Financial sector exposure represents 27.50% of the portfolio, making the ETF particularly vulnerable to the fortunes of major banking institutions. The ability of HDFC Bank and ICICI Bank to reverse the current market slide will substantially influence the fund’s direction.

Competitive Fee Structure Offers Silver Lining

Among its competitive advantages, FLIN maintains an expense ratio of just 0.19%, positioning it favorably against alternative India-focused products like the iShares MSCI India ETF (INDA) and WisdomTree India Earnings Fund (EPI). Whether this cost benefit can retain investor interest during market declines remains uncertain.

Market observers noted a potential shift on September 29, 2025, when Indian benchmark indices snapped a six-day losing streak, driven primarily by strength in IT, oil and gas, and metal stocks. The critical question for investors is whether this represents a genuine trend reversal or merely a temporary pause before further declines.

Ad

Franklin FTSE India ETF Stock: Buy or Sell?! New Franklin FTSE India ETF Analysis from March 25 delivers the answer:

The latest Franklin FTSE India ETF figures speak for themselves: Urgent action needed for Franklin FTSE India ETF investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Franklin FTSE India ETF: Buy or sell? Read more here...

Tags: Franklin FTSE India ETF
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Technology Select Sector SPDR® Fund Stock
AI & Quantum Computing

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

March 25, 2026
VanEck Junior Gold Miners UCITS ETF Stock
Commodities

VanEck’s Junior Gold ETF Overhauls Holdings with Major Additions

March 24, 2026
SPDR® S&P® U.S. Dividend Aristocrats UCITS ETF (Dist) Stock
Dividends

A Quarterly Review of the SPDR S&P U.S. Dividend Aristocrats ETF

March 24, 2026
Next Post
Cassava Sciences Stock

Cassava Sciences Shares Experience Dramatic Volatility Following CEO's Major Investment

Caterpillar Stock

Caterpillar Shares Approach Historic Threshold Amid Market Optimism

Fortinet Stock

Fortinet Faces Securities Fraud Allegations Over Product Upgrade Cycle

Recommended

Alphabet Stock

Alphabet Shares Face Regulatory Headwinds Despite Autonomous Driving Breakthrough

4 months ago
Dish Network Stock

Institutional Investors Show Diverging Views on Dish Network’s Future

7 months ago
Finance_ Trading ratings today (2)

Lakeland Financial Exceeds Expectations with Fourth Quarter Earnings

2 years ago
DeFi Technologies Stock

DeFi Technologies: Navigating Expansion Amidst Legal Headwinds

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Trending

BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

by Kennethcix
March 25, 2026
0

BioNano Genomics has wrapped up its fiscal year 2025, presenting a financial picture marked by significant operational...

Humacyte Stock

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Evolent Health Stock

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026
MongoDB Stock

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Talphera Stock

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds
  • Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts
  • Evolent Health Bets on AI Leadership Amid Share Price Decline

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com